Grifols, S.A. News Headlines

GRFS 
$35.32
*  
1.56
4.23%
Get GRFS Alerts
*Delayed - data as of Sep. 23, 2014  -  Find a broker to begin trading GRFS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

European ADRs Decline, Dragged Down By Oil, Pharmaceuticals
9/23/2014 10:47:32 AM - MT Newswires

Investors Should Exercise Caution With REVO Biologics IPO
9/16/2014 8:22:00 AM - Seeking Alpha

European ADRs Pulled down by Contractions in Pharmaceutical Stocks
9/11/2014 10:48:59 AM - MT Newswires

Grifols (GRFS) Shares Cross Above 200 DMA
8/25/2014 11:50:32 AM - BNK Invest

Tracking John Paulson's Paulson & Company Portfolio - Q2 2014 Update
8/18/2014 8:09:00 AM - Seeking Alpha

GRFS Crosses Below Key Moving Average Level
7/31/2014 1:41:15 PM - BNK Invest

Markets end July undecided
7/31/2014 8:42:00 AM - Market Intelligence Center

Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape
6/24/2014 8:35:00 AM - Zacks.com

Positive Phase IIb Data from Jazz Pharma - Analyst Blog
6/5/2014 6:56:00 PM - Zacks.com

Zacks Rank #1 Additions for Thursday - Tale of the Tape
6/5/2014 9:30:00 AM - Zacks.com

Grifols, S.A. (GRFS) Ex-Dividend Date Scheduled for June 05, 2014
6/4/2014 9:00:01 AM - NASDAQ.com News

Patients Enrolled in Avanir Study - Analyst Blog
6/2/2014 5:35:00 PM - Zacks.com

Pipeline Update from Avanir - Analyst Blog
6/2/2014 5:00:00 PM - Zacks.com

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
5/28/2014 9:30:00 AM - Zacks.com

Zacks Rank #1 Additions for Thursday - Tale of the Tape
5/22/2014 9:30:00 AM - Zacks.com

Tracking John Paulson's Paulson & Company Portfolio - Q1 2014 Update
5/18/2014 2:44:00 PM - Seeking Alpha

Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9% - Tale of the Tape
4/17/2014 9:04:01 AM - Zacks.com

Flamel Technologies (FLML) in Focus: Stock Slumps 13.5% - Tale of the Tape
4/15/2014 8:54:01 AM - Zacks.com

Pharmacyclics (PCYC) Crumbles: Stock Falls by 7.7% - Tale of the Tape
4/14/2014 11:00:01 AM - Zacks.com

PharmAthene (PIP) Crumbles: Stock Falls by 7.1% - Tale of the Tape
4/11/2014 8:51:01 AM - Zacks.com

Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape
4/10/2014 9:21:01 AM - Zacks.com

Endocyte (ECYT) in Focus: Stock Tumbles 8.3% - Tale of the Tape
3/28/2014 8:47:01 AM - Zacks.com

Grifols (GRFS): An Off-the-Radar Potential Winner - Tale of the Tape
3/18/2014 8:50:01 AM - Zacks.com

New Analyst Coverage - Screen of the Week
3/11/2014 4:01:01 AM - Zacks.com

The Power of New Analyst Coverage - Screen of the Week
3/11/2014 4:01:01 AM - Zacks.com